United Kingdom · Question · Written question
UIN 95051
Omaveloxolone: Friedreich's Ataxia
Original
Introduced
27 November 2025
Last action
3 December 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
3 December 2025
Summary
To ask the Secretary of State for Health and Social Care, if he will take steps to introduce interim access to omaveloxolone for Friedreich’s Ataxia patients.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
27 November 2025
Written question
To ask the Secretary of State for Health and Social Care, if he will take steps to introduce interim access to omaveloxolone for Friedreich’s Ataxia patients.
Source: Commons
3 December 2025
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based recommendations for the National Health Service on whether new, licensed medicines represent a clinically and cost-effective use...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-11-27/95051
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1858024
- uk · wq-1858024 · source updated 3 December 2025